Sheehan, D., Meade, G., Foley, V
PLoS One 10(9)
To date, there is only one published human study of BPC-157: a retrospective survey of sixteen people who had it injected into a painful knee, with no control group and no placebo, asked months later whether they felt better [14]
For patients who want a stronger appetite effect, we also discuss tirzepatide (Mounjaro) as an alternative
The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke